Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

BACKGROUND: Esophageal adenocarcinoma is a lethal disease. For locally advanced patients, neoadjuvant chemoradiotherapy followed by surgery is the standard of care. Risk stratification relies heavily on clinicopathologic features, particularly pathologic response, which is inadequate, therefore esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Matani, Hirsch, Sahu, Divya, Paskewicz, Michael, Gorbunova, Anastasia, Omstead, Ashten N., Wegner, Rodney, Finley, Gene G., Jobe, Blair A., Kelly, Ronan J., Zaidi, Ali H., Goel, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664643/
https://www.ncbi.nlm.nih.gov/pubmed/36376989
http://dx.doi.org/10.1186/s40364-022-00429-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664643/
https://www.ncbi.nlm.nih.gov/pubmed/36376989
http://dx.doi.org/10.1186/s40364-022-00429-6

Ejemplares similares